Bexagliflozin
NDC 51407-918, Bexagliflozin, tablet, from Golden State Medical Supply, Inc..
- Product NDC
- 51407-918
- Status
- Listed
- Labeler
- Golden State Medical Supply, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA214373
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51407-918 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BEXAGLIFLOZIN20 mg/1
Pharmacologic classes
Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51407-918-30 | 51407091830 | 30 TABLET in 1 BOTTLE (51407-918-30) |
| 51407-918-90 | 51407091890 | 90 TABLET in 1 BOTTLE (51407-918-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1a3ba9d5-1009-bad0-e063-6294a90ac4cc
Use it
Look up 51407-918 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51407-918 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51407-918. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.